Compare IRON & BRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IRON | BRC |
|---|---|---|
| Founded | 2017 | 1914 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Miscellaneous manufacturing industries |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.6B | 4.1B |
| IPO Year | 2020 | 2005 |
| Metric | IRON | BRC |
|---|---|---|
| Price | $87.40 | $82.42 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 13 | 2 |
| Target Price | ★ $126.77 | $110.00 |
| AVG Volume (30 Days) | ★ 1.4M | 222.8K |
| Earning Date | 11-05-2026 | 11-24-2026 |
| Dividend Yield | N/A | ★ 1.25% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $1,144,698,000.00 |
| Revenue This Year | N/A | $74.03 |
| Revenue Next Year | N/A | $3.84 |
| P/E Ratio | ★ N/A | $23.35 |
| Revenue Growth | N/A | ★ 5.86 |
| 52 Week Low | $40.00 | $70.57 |
| 52 Week High | $99.50 | $99.29 |
| Indicator | IRON | BRC |
|---|---|---|
| Relative Strength Index (RSI) | 65.42 | 50.34 |
| Support Level | $65.04 | $80.12 |
| Resistance Level | N/A | $86.96 |
| Average True Range (ATR) | 3.82 | 2.45 |
| MACD | 0.55 | 0.01 |
| Stochastic Oscillator | 97.64 | 54.32 |
Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs), including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.
Brady Corp provides identification solutions and workplace safety products. The company offers identification and healthcare products that are sold under the Brady brand to maintenance, repair, and operations as well as original equipment manufacturing customers. Products include safety signs and labeling systems, material identification systems, wire identification, patient identification, and people identification. Brady also provides workplace safety and compliance products such as safety and compliance signs, asset tracking labels, and first-aid products. The company is organized and managed on a geographic basis with two reportable segments: Americas & Asia which derives maximum revenue, and Europe & Australia.